Literature DB >> 11115900

Decision analysis of prophylactic treatment for patients with high-risk esophageal varices.

N Aoki1, T Kajiyama, J R Beck, R W Cone, K Soma, T Fukui.   

Abstract

BACKGROUND: Clinical decision analyses were conducted to quantify the uncertainty and to identify important factors in selection of prophylactic therapy for patients with esophageal varices.
METHODS: A Markov model compared variceal ligation, beta-blockers, and "watchful waiting" strategies in terms of bleeding-free life years. Transition probabilities were obtained from meta-analyses of published data. A hypothetical 50-year-old white man with high-risk esophageal varices and cirrhosis served as the prototypical baseline case. Traditional n-way sensitivity analyses were applied to clarify the influence of each factor, and Monte Carlo probabilistic sensitivity analyses were used to investigate clinical uncertainty.
RESULTS: Probabilistic sensitivity analyses demonstrated that 77.0% of hypothetical cases had more bleeding-free life years after variceal ligation, whereas 23% had more when treated with beta-blockers. On the basis of one-way sensitivity analyses, only 2 factors (variceal bleeding rates after ligation and treatment with beta-blockers) influenced the strategy choice.
CONCLUSIONS: Variceal ligation is an effective prophylactic therapy in many cases, but nearly one quarter of patients with high-risk esophageal varices and cirrhosis may benefit more from prophylactic treatment with beta-blockers. Additional clinical studies identifying key variceal bleeding risk factors may lead to more effective clinical decision making for these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115900     DOI: 10.1067/mge.2000.110729

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  3 in total

1.  Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization.

Authors:  Kenji Ohmoto; Naoko Yoshioka; Yasuyuki Tomiyama; Norikuni Shibata; Michihiko Takesue; Koji Yoshida; Makoto Kuboki; Shinichiro Yamamoto
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

2.  High-risk esophageal varices in patients treated with locoregional therapies for hepatocellular carcinoma: evaluation with regular follow-up liver CT.

Authors:  Hyojin Kim; Dongil Choi; Geum-Youn Gwak; Joon Hyeok Lee; Soon Jin Lee; Seong Hyun Kim; Ji Young Lee; Yulri Park; Ilsoo Chang; Hyo K Lim
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

3.  The magnitude and correlates of esophageal Varices among newly diagnosed cirrhotic patients undergoing screening fibre optic endoscope before incident bleeding in North-Western Tanzania; a cross-sectional study.

Authors:  Daniel W Gunda; Semvua B Kilonzo; Zakhia Mamballah; Paulina M Manyiri; David C Majinge; Hyasinta Jaka; Benson R Kidenya; Humphrey D Mazigo
Journal:  BMC Gastroenterol       Date:  2019-11-29       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.